In this study, all the invasive carcinomas were positive for STS, which is in agreement with Tseng et al.9 who measured STS activity ranging from 0.2 to 4.6 nmol/mg tissue protein per hr in 66 breast carcinomas. The gene discussed is STS; the disease is breast carcinoma.